Stay updated on BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial
Sign up to get notified when there's something new on the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page.

Latest updates to the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page
- Check2 days agoChange DetectedA bibliographic entry for a Lancet publication about Spesolimab use in generalised pustular psoriasis flares has been removed from the Publications section. This update does not change the study design, endpoints, or results.SummaryDifference0.0%

- Check9 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a newer release of the page content.SummaryDifference0.0%

- Check17 days agoChange DetectedThe revision label on the related documents was updated from v3.6.0 to v3.6.2, signaling a newer version of the materials accompanying the study.SummaryDifference0.0%

- Check31 days agoChange DetectedThe study page now indicates recruitment is closed ('No longer looking for participants'), signaling that active enrollment has ended. New user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a formatting update to the Intervention/Treatment label and a revision bump to v3.6.0.SummaryDifference0.2%

- Check38 days agoChange DetectedA new revision tag v3.5.5 is shown, replacing the previous v3.5.4, indicating a minor document version update.SummaryDifference0.0%

- Check60 days agoChange DetectedA new revision label, v3.5.4, appears on the page, replacing the previous v3.5.3. This reflects a metadata revision update rather than a substantive change to the study content.SummaryDifference0.0%

Stay in the know with updates to BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page.